FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange on Friday, March 6, 2020

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"\n\n\n\nFSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange on Friday, March 6, 2020\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, March 4, 2020\n\n\n\n– Reports audited financial results for the Fourth Quarter and Full Year ended December 31, 2019 –\n TORONTO, March 4, 2020 /CNW/ - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9A) (\"FSD Pharma\" or the \"Company\") today announced that Executive Co-Chairman and CEO, Raza Bokhari, MD will be joined by the Company's founders, Anthony Durkacz and Zeeshan Saeed, members of its Board of Directors, and leadership team to ring the opening bell at the Canadian Securities Exchange (CSE) on Friday, March 6, 2020 at 9:30 a.m. Eastern time. \n\n \n \n \n \n \n \n\n \nThe Market Open Ceremony will be held at the CSE Media Centre in Toronto and will be webcast live beginning at 9:28 a.m. Eastern time via the following link: https://www.instagram.com/canadiansecuritiesexchange/ and available on replay at the following link: https://www.youtube.com/channel/UCHAlYSqAf_2dGADm9yiqTiw\n\"We are immensely thrilled to ring the opening bell at the CSE to celebrate our accomplishment as the first CSE-listed company to dual-list onto a major U.S. stock exchange,\" said Raza Bokhari, MD, Executive Co-Chairman & CEO. \"Having raised a record $53 million in pre-listing capital and following our listing on the CSE in May 2018, we have continued to demonstrate a track record of success that is reflected in trading liquidity that tops 6 billion shares to date that is among the volume leaders on the CSE.\n\"Today, we are among a select group of 12 Canadian-domiciled, cannabis-related companies that trade on a major U.S. exchange. I am very hopeful that sooner rather than later, we will be placed in a league of our own as we continue to demonstrate that the primary thrust of our business is to conduct U.S. FDA-approved clinical trials on synthetic compounds with anti-inflammatory properties that target the endoca...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B